Today’s Solutions: December 20, 2025

Once it was scientifically-proven that glyphosate, the main ingredient in Monsanto’s weedkiller Roundup, causes cancer, a school groundskeeper from California took Monsanto to court. Lee Johnson was diagnosed with cancer in 2014, following years of mixing and using the weedkiller at his job site in Benicia, California, and now Monsanto will pay $289 million for the damages after jurors found them guilty at a court in San Francisco.

Glyphosate was approved for use by Monsanto in 1974 and, today, Roundup is the world’s most popular herbicide. This decision has significant implications for the German company, Bayer AG, which bought Monsanto in June 2018, as it creates “huge potential liability” for the corporation.

The trial was an important test of the evidence against Monsanto and will serve as a template for litigating thousands of other claims over the herbicide. Despite the decision, Monsanto and its legal team maintain that there is no link between glyphosate and cancerous growth. 

Read the full article below to learn more about the court case and the science behind chemical-based herbicides:

Solutions News Source Print this article
More of Today's Solutions

Try this simple breathing exercise to rid yourself of cold hands and feet

Do you often find that your hands and feet are colder than the rest of your body? This can be perplexing, especially when gloves ...

Read More

Roman jars reveal the secrets of ancient winemaking

Archaeologists are still putting the full story of human history together. From the discovery of a Viking shipyard in Sweden to the Sistine Chapel ...

Read More

Cancer detection breakthrough revealed via butterfly-inspired imaging

In the world of sensory perception, other creatures frequently outperform humans. A research team has created an imaging sensor that looks into the elusive ultraviolet ...

Read More

Advancements in vision restoration: CRISPR gives hope to patients 

In a revolutionary development, CRISPR gene editing emerged as a beacon of hope for people suffering from genetic blindness. The results of a Phase ...

Read More